Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Abbott Laboratories	AbbVie	Pfizer	Merck & Co., Inc.	Novartis
Symbol	NYSE:ABT	NYSE:ABBV	NYSE:PFE	NYSE:MRK	NYSE:NVS
Price Information
Current Price	$119.60	$106.53	$34.19	$73.20	$87.39
52 Week Range	Buy	Buy	Hold	Buy	Hold
MarketRank™
Overall Score	2.4	2.8	2.6	2.4	2.1
Analysis Score	2.4	1.4	3.1	3.4	3.2
Community Score	2.8	2.9	2.9	2.5	2.3
Dividend Score	3.3	5.0	3.3	2.5	2.5
Ownership Score	1.7	1.7	1.7	1.7	0.0
Earnings & Valuation Score	1.9	3.1	1.9	1.9	2.5
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	Buy	Hold
Consensus Price Target	$121.83	$115.50	$39.53	$95.36	$111.00
% Upside from Price Target	1.87% upside	8.42% upside	15.63% upside	30.27% upside	27.02% upside
Trade Information
Market Cap	$217.07 billion	$190.45 billion	$186.26 billion	$184.31 billion	$201.79 billion
Beta	0.83	0.84	0.7	0.43	0.59
Average Volume	5,252,399	7,512,778	35,308,766	10,825,183	2,128,972
Sales & Book Value
Annual Revenue	$31.90 billion	$33.27 billion	$51.75 billion	$46.84 billion	$47.50 billion
Price / Sales	6.64	5.66	3.67	3.95	4.21
Cashflow	$5.36 per share	$9.96 per share	$3.81 per share	$5.95 per share	$7.39 per share
Price / Cash	22.31	10.70	8.97	12.31	11.82
Book Value	$17.70 per share	($5.53) per share	$11.46 per share	$10.21 per share	$24.53 per share
Price / Book	6.76	-19.26	2.98	7.17	3.56
Profitability
Net Income	$3.69 billion	$7.88 billion	$16.27 billion	$9.84 billion	$11.73 billion
EPS	$3.24	$8.94	$2.95	$5.19	$5.24
Trailing P/E Ratio	63.28	22.52	22.06	16.19	28.28
Forward P/E Ratio	27.31	8.75	11.17	12.06	13.40
P/E Growth	2.06	1.54	2.79	1.89	1.76
Net Margins	10.50%	18.16%	17.85%	24.33%	14.71%
Return on Equity (ROE)	18.19%	439.24%	24.88%	53.83%	24.39%
Return on Assets (ROA)	8.29%	13.22%	9.32%	16.83%	10.59%
Dividend
Annual Payout	$1.80	$5.20	$1.56	$2.60	$2.01
Dividend Yield	1.51%	4.88%	4.56%	3.55%	2.30%
Three-Year Dividend Growth	35.85%	84.37%	-10.94%	31.22%	N/A
Payout Ratio	55.56%	58.17%	52.88%	50.10%	38.36%
Years of Consecutive Dividend Growth	49 Years	49 Years	1 Years	1 Years	1 Years
Debt
Debt-to-Equity Ratio	0.58%	5.38%	0.76%	0.90%	0.49%
Current Ratio	1.70%	0.95%	1.40%	1.30%	0.91%
Quick Ratio	1.19%	0.81%	1.13%	1.00%	0.69%
Ownership Information
Institutional Ownership Percentage	72.58%	67.49%	67.36%	72.86%	9.86%
Insider Ownership Percentage	1.70%	0.09%	0.08%	0.28%	0.01%
Miscellaneous
Employees	107,000	47,000	88,300	71,000	110,000
Shares Outstanding	1.77 billion	1.77 billion	5.56 billion	2.53 billion	2.29 billion
Next Earnings Date	4/15/2021 (Estimated)	5/7/2021 (Estimated)	4/27/2021 (Estimated)	4/29/2021 (Confirmed)	4/27/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources